Please note ThinkMarkets does not provide CFD services to residents of the US.

Please note ThinkMarkets does not provide CFD services to residents of the US.

Learn To Trade
 
Indicators & Chart Patterns

Deepen your knowledge of technical analysis indicators and hone your skills as a trader.

Find your detailed guides here
Trading Glossary

From beginners to experts, all traders need to know a wide range of technical terms. Let us be your guide.

Learn more
Knowledge Base

No matter your experience level, download our free trading guides and develop your skills.

Learn more
Learn To Trade

Trade smarter: boost your skills with our training resources.

Create a live account
Market Analysis
 
Market News

All the latest market news, with regular insights and analysis from our in-house experts

Learn more
Economic Calendar

Make sure you are ahead of every market move with our constantly updated economic calendar.

Learn more
Technical Analysis

Harness past market data to forecast price direction and anticipate market moves.

Learn more
Live Webinars

Boost your knowledge with our live, interactive webinars delivered by industry experts.

Register now
Special Reports

Engaging, in-depth macroeconomic analysis and expert educational content from our in-house analysts

Learn more
Market Analysis

Harness the market intelligence you need to build your trading strategies.

Create a live account
Partnership
 
Affiliate Programme

Grow your business and get rewarded. Find out more about our Affiliate Programme today.

Learn more
Introducing Broker

ThinkMarkets ensures high levels of client satisfaction with high client retention and conversion rates.

Learn more
Proprietary Trading

Partner with us to build your own prop trading business. Enquire with our account managers today.

Learn more
White Label

We supply everything you need to create your own brand in the Forex industry.

Learn more
Regional Representatives

Partner with ThinkMarkets today to access full consulting services, promotional materials and your own budgets.

Learn more
Refer a friend

Receive $50 for you and your friend when you convert them into an active trader of ThinkMarkets.

Learn more
Partnership

Plug into the next-gen platforms and the trades your clients want.

Partner Portal
About ThinkMarkets
 
Sponsorships

Check out our sponsorships with global institutions and athletes, built on shared values of excellence.

Learn more
About Us

Find out more about ThinkMarkets, an established, multi-award winning global broker you can trust.

Learn more
Careers

Discover a range of rewarding career possibilities across the globe

Apply now
ThinkMarkets News

Keep up to date with our latest company news and announcements

Learn more
Trading Infrastructure

When it comes to the speed we execute your trades, no expense is spared. Find out more.

Learn more
Contact Us

Our multilingual support team is here for you 24/7.

Learn more
About ThinkMarkets

Global presence, local expertise - find out what sets us apart.

Create a live account
Log in Create account

FTSE stage set for breakout as UK approves vaccine

Fawad Razaqzada Fawad Razaqzada 02/12/2020
FTSE stage set for breakout as UK approves vaccine FTSE stage set for breakout as UK approves vaccine
FTSE stage set for breakout as UK approves vaccine Fawad Razaqzada
The big news this morning was once again from the vaccine front as UK became the first western country to approve a Covid-19 shot. While the reaction to the news was somewhat muted as the markets have already been pricing in an improved health outlook throughout November, this should help to keep UK stocks – especially those in the travel and hospitality sectors – supported, nonetheless. Critics will argue about vaccine’s safety and many people will be probably think twice before taking the shot. But ultimately, vaccine is our best hope to live in a Covid world, so I think a lot of people will slowly take the shot and life could return to normalcy by the middle of 2021.

The first 800,000 doses of the vaccine will be available in the UK from next week, according to Health Secretary Matt Hancock. Elderly people, especially those in care homes and staff working there are top of the priority list. Then, next in the line will be the over-80s and health and care staff. The working population will have to wait, but the UK government has already placed enough orders (40 million doses) to vaccinate around 20 million people.

Apart from vaccines, it is a struggle to look for fresh catalysts elsewhere. There is still no end in sight for the stalemate in Brexit talks. The same could be said about stimulus talks in the EU and US. Meanwhile, the virus is continuing to spread rapidly in the US, as well as large parts of Europe. The economic impact of the latest lockdowns could be severe, and the jobs that have been lost will be very slow to regain as many companies have gone bust – not least Debenhams, which failed to  secure last-ditch efforts to rescue the store chain.
 
Technical outlook

The FTSE has spent the last couple of weeks in a relatively tight range, digesting the recent macro events and taking a pause following the rally that started in early November. This bullish consolidation has allowed popular momentum indicators such as the Relative Strength Index (RSI) to work off their ‘overbought’ conditions through time than price action. This is potentially bullish as it indicates the sellers have been unable to cause much damage, while momentum-chasing investors who until now might have been on the side-lines, will now be encouraged by the RSI being no longer overbought.

Thus, the FTSE looks poised to break above resistance circa 6440 before potentially heading sharply higher.

FTSESource: ThinkMarkets and TradingView.com

Some of the bullish objectives include the Fibonacci retracement levels shown on the chart, at 6576 (61.8%) and 7063 (78.6%).

However, if instead of breaking out, the FTSE breaks down below 6245 support, then in that event we could see a deeper retracement, perhaps to the next key support down at 5950, before the index potentially resumes higher.
Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice. ThinkMarkets will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information.

Related articles:

RDDT soars: here are the levels to watch in c...

By Alejandro Zambrano

26/03/2024

Weekly Market Outlook - 25 MAR to 29 MAR 2024

By

25/03/2024

Weekly Index Dividends

By ThinkMarkets

25/03/2024

Reddit Launches IPO: Can the Struggling Compa...

By Alejandro Zambrano

21/03/2024

Weekly Market Outlook - 18 MAR to 22 MAR 2024

By ThinkMarkets

18/03/2024

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice. ThinkMarkets will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information.
Back to top